<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Accumulated evidence suggests that <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and impairments in cerebral insulin receptor signaling may contribute to age-related <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The enhancement of insulin receptor signaling is, therefore, a promising strategy for the treatment of age-related <z:e sem="disease" ids="C0009241" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive disorders</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> respiratory chain, being involved in insulin-stimulated <z:chebi fb="0" ids="30492">H2O2</z:chebi> production, has been identified recently as a potential target for the enhancement of insulin signaling </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of the present study is to examine: (1) whether a specific respiratory substrate, dicholine salt of <z:chebi fb="3" ids="15741">succinic acid</z:chebi> (CS), can enhance insulin-stimulated insulin receptor autophosphorylation in neurons, and (2) whether CS can ameliorate <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> of various origins in animal models </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In a primary culture of cerebellar granule neurons, CS significantly enhanced insulin-stimulated insulin receptor autophosphorylation </plain></SENT>
<SENT sid="5" pm="."><plain>In animal models, CS significantly ameliorated <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo>, when administered intraperitoneally for 7 days </plain></SENT>
<SENT sid="6" pm="."><plain>In 16-month-old middle-aged C57Bl/6 mice (a model of <z:mpath ids='MPATH_458'>normal</z:mpath> aging), CS enhanced spatial learning in the <z:mp ids='MP_0001465'>Morris water maze</z:mp>, spontaneous locomotor activity, passive avoidance performance, and increased brain N-acetylaspartate/<z:chebi fb="2" ids="16919">creatine</z:chebi> levels, as compared to the age-matched control (saline) </plain></SENT>
<SENT sid="7" pm="."><plain>In rats with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e>, CS enhanced spatial learning, passive avoidance performance, and increased brain N-acetylaspartate/<z:chebi fb="2" ids="16919">creatine</z:chebi> levels, as compared to control rats (saline) </plain></SENT>
<SENT sid="8" pm="."><plain>In rats with beta-amyloid <z:chebi fb="7" ids="16670">peptide</z:chebi>-(25-35)-induced <z:e sem="disease" ids="C0002622" disease_type="Mental or Behavioral Dysfunction" abbrv="">amnesia</z:e>, CS enhanced passive avoidance performance and increased activity of brain <z:chebi fb="3" ids="15354">choline</z:chebi> acetyltransferase, as compared to control rats (saline) </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> used models, CS effects lasted beyond the seven-day treatment period and were found to be significant about two weeks following the treatment </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: The results of the present study suggest that dicholine salt of <z:chebi fb="3" ids="15741">succinic acid</z:chebi>, a novel neuronal insulin sensitizer, ameliorates <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> and neuronal dysfunctions in animal models relevant to age-related <z:hpo ids='HP_0100543'>cognitive impairments</z:hpo>, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
</text></document>